Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Reserpine (N1867): Practical Research Workflow
2026-09-02
Reserpine (SKU N1867) provides a characterized research reagent for controlled neurotransmitter depletion, antihypertensive mechanism, and neuropharmacology workflows where solvent compatibility and solution freshness affect reproducibility. It is intended for research use only and should not be used for diagnostic, therapeutic, medical, or veterinary applications.
-
MOG (35-55) EAE Research Workflow
2026-09-01
Build reproducible autoimmune encephalomyelitis research around a defined myelin antigen, from peptide handling and EAE induction to neuroinflammation assay design. This workflow also shows how MOG-driven disease phenotypes can be paired with PARP7–STAT1/STAT2 measurements for mechanism-focused multiple sclerosis research.
-
Berberine Hydrochloride in AKI Assay Design
2026-09-01
Berberine hydrochloride offers a mechanistically rich tool for metabolic, cancer, and inflammation research. This article develops a distinct assay strategy connecting its AMPK-centered biology with oxidized self-DNA and NLRP3-driven acute kidney injury while clearly separating established evidence from testable hypotheses.
-
Gramine–CUL3–MTDH Axis in TNBC Ferroptosis
2026-08-31
The reference study identifies Gramine as a selective suppressor of triple-negative breast cancer through a CUL3–MTDH regulatory axis that activates ferroptosis. By combining target-engagement assays, genetic perturbation, ferroptosis-rescue experiments, and xenograft models, the authors connect CUL3 modulation with changes in MTDH, SLC3A2, GPX4, redox balance, and tumor growth.
-
AO/PI Double Staining Kit: Practical Guide
2026-08-31
The AO/PI Double Staining Kit provides a rapid fluorescent cell staining workflow for separating viable, apoptotic, and necrotic cell populations by color. It is appropriate for comparative cell viability, apoptosis detection, and necrosis detection, but it should not be treated as a standalone method for confirming a specific apoptotic pathway or replacing orthogonal validation.
-
AG-221 (Enasidenib) Workflow for IDH2 AML
2026-08-30
Build a mechanism-led AML workflow around AG-221 (Enasidenib) by pairing 2-HG measurements with viability and differentiation assays. The approach extends IDH2 inhibition into CD44-linked metabolic rewiring studies, helping distinguish on-target responses from nonspecific cytotoxicity.
-
Carbenoxolone disodium: Practical Lab Guide
2026-08-29
Carbenoxolone disodium (SKU A8389) is a mechanistic research reagent for studying 11β-hydroxysteroid dehydrogenase activity, glucocorticoid access, and gap junction communication in cell- and tissue-based systems. It is appropriate for controlled pathway experiments, but not for interpreting in vivo efficacy or selective target effects when viability and off-target activity cannot be separated.
-
TEAD2, Ferroptosis, and HCC Prognosis
2026-08-28
Ren et al. combined public cancer databases with in vitro validation to identify TEAD2 and TEAD4 as elevated in hepatocellular carcinoma, while linking TEAD2 expression to adverse survival and ferroptosis regulation. The study positions TEAD2 as a candidate prognostic and mechanistic target, although its clinical and therapeutic relevance requires validation in larger cohorts and in vivo models.
-
PPM-18: A Redox-Aware iNOS Research Strategy
2026-08-28
PPM-18 is an NF-κB-linked iNOS expression inhibitor for dissecting inflammatory nitric oxide biology. This article connects its transcriptional mechanism with redox-sensitive cardiac signaling and provides assay-planning guidance for inflammation and sepsis research.
-
X-Gal Workflows for Cloning and Assay Troubleshooting
2026-08-27
Use X-Gal to turn lacZα complementation into a rapid visual checkpoint for molecular cloning, then extend the same construct-validation logic to reporter and cell-based experiments. This guide combines practical screening conditions, assay-selection advice, and troubleshooting with insights from iRhom2 olfaction research.
-
Brefeldin A: From Trafficking Block to ER Stress
2026-08-27
Brefeldin A is more than a vesicle transport inhibitor: it is a controlled way to connect ER–Golgi disruption with proteostasis, ER stress, and cancer-cell fate. This guide translates UBR1/UBR2 findings into practical assay decisions and interpretable BFA workflows.
-
Tigecycline in the New Era of CREC Transmission
2026-08-26
Carbapenemase mobility is reshaping multidrug-resistance research. This thought-leadership guide positions Tigecycline as a mechanistically distinct translational tool for connecting CREC genomics, susceptibility testing, MRSA research, and infection-model design without overstating what genotype alone can predict.
-
Solanesol B8776: Practical Research Workflow Guide
2026-08-26
Solanesol is a hydrophobic polyisoprenoid alcohol for controlled biochemical and pharmaceutical research workflows, including apoptosis research, DNA damage and repair studies, metabolic enzyme assays, and protease activity research. This guide addresses solvent selection, fresh-solution handling, precipitation control, and assay controls; the material is not suitable for water- or ethanol-only systems, diagnostic use, or medical applications.
-
Cinoxacin: From MIC to Translational Assay Design
2026-08-25
Cinoxacin is a quinolone antibiotic with a defined Gram-negative activity profile and practical value in urinary tract infection research. This article develops an assay-design framework that connects MIC interpretation, exposure-aware experiments, resistance studies, and lessons from precision clinical-trial methodology.
-
Erastin Workflows for Ferroptosis Research
2026-08-25
Erastin is a practical ferroptosis inducer for connecting RAS/BRAF genotype, cystine–glutathione depletion, oxidative stress, and tumor-cell viability. This workflow covers fresh-solution handling, orthogonal assay design, pancreatic cancer applications, and troubleshooting strategies that help distinguish ferroptosis from nonspecific cytotoxicity.